Calcitonin gene‐related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat
- 1 August 2004
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 142 (7), 1171-1181
- https://doi.org/10.1038/sj.bjp.0705807
Abstract
Calcitonin gene-related peptide (CGRP) is released into the cranial circulation of humans during acute migraine. To determine whether CGRP is involved in neurotransmission in craniovascular nociceptive pathways, we microiontophoresed onto neurons in the trigeminocervical complex and intravenously administered the CGRP receptor antagonists α-CGRP-(8–37) and BIBN4096BS. Cats were anaesthetised with α-chloralose, and using halothane during surgical preparation. A craniotomy and C1/C2 laminectomy allowed access to the superior sagittal sinus (SSS) and recording site. Recordings of activity in the trigeminocervical complex evoked by electrical stimulation of the SSS were made. Multibarrelled micropipettes incorporating a recording electrode were used for microiontophoresis of test substances. Cells recorded received wide dynamic range (WDR) or nociceptive specific (NS) input from cutaneous receptive fields on the face or forepaws. Cell firing was increased to 25–30 Hz by microiontophoresis of L-glutamate (n=43 cells). Microiontophoresis of α-CGRP excited seven of 17 tested neurons. BIBN4096BS inhibited the majority of units (26 of 38 cells) activated by L-glutamate, demonstrating a non-presynaptic site of action for CGRP. α-CGRP-(8–37) inhibited a similar proportion of units (five of nine cells). Intravenous BIBN4096BS resulted in a dose-dependent inhibition of trigeminocervical SSS-evoked activity (ED50 31 μg kg–1). The maximal effect observed within 30 min of administration. The data suggest that there are non-presynaptic CGRP receptors in the trigeminocervical complex that can be inhibited by CGRP receptor blockade and that a CGRP receptor antagonist would be effective in the acute treatment of migraine and cluster headache.This publication has 77 references indexed in Scilit:
- Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene‐related peptide induced dilation of dural meningeal vesselsBritish Journal of Pharmacology, 2002
- GABA receptors modulate trigeminovascular nociceptive neurotransmission in the trigeminocervical complexBritish Journal of Pharmacology, 2001
- Non‐NMDA glutamate receptors modulate capsaicin induced c‐fos expression within trigeminal nucleus caudalisBritish Journal of Pharmacology, 1999
- Comparison of More and Less Lipophilic Serotonin (5HT1B/1D) Agonists in a Model of Trigeminovascular Nociception in CatExperimental Neurology, 1998
- The NMDA receptor antagonist MK-801 reduces Fos-like immunoreactivity in central trigeminal neurons and blocks select endocrine and autonomic responses to corneal stimulation in the ratPain, 1996
- Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptanThe Lancet, 1991
- Vasoactive peptide release in the extracerebral circulation of humans during migraine headacheAnnals of Neurology, 1990
- Differentiation of excitatory amino acid receptors in the rat caudal trigeminal nucleus: A microiontophoretic studyNeuropharmacology, 1982
- To spritz or not to spritz: The doubtful value of aimless iontophoresisLife Sciences, 1974
- Alterations Produced by Cortisol in the Spontaneous Activity and Responsiveness to Sensory Stimuli of Single Cells in the Tuberal Hypothalamus of the RatNeuroendocrinology, 1973